0HR1X72
Replacement Skin, Face to Cell Suspension Technique with Autologous Tissue Substitute, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | H Skin and Breast |
| Operation | R Replacement |
| Body Part | 1 Skin, Face |
| Approach | X External |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | 2 Cell Suspension Technique |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in the skin and breast involve putting in material, biological or synthetic, that physically takes over for tissue that has been removed or is absent. The clearest example is breast implant placement following mastectomy, where a saline or silicone implant substitutes for the breast tissue that was removed. Skin grafting for extensive wounds or burns, where donor or synthetic skin substitutes for tissue that cannot heal on its own, also falls into this family.
These procedures are performed when tissue loss is too extensive for simple repair, or when a body part such as the breast has been surgically removed and the patient elects reconstruction. The replacement material can come from the patient's own body, a donor, or be entirely synthetic, and it is meant to remain in place, unlike a temporary dressing or expander used only to stretch skin.
Timing varies considerably: some replacements happen in the same operation as the tissue removal, known as immediate reconstruction, while others are staged over months, especially when tissue expanders are used first to prepare the site before the permanent implant or flap is placed.
Anatomy & Axis Detail
Skin, Face
Facial skin replacement addresses loss or destruction of the epidermal and dermal covering over the cheeks, forehead, nose, and periorbital regions, most often after Mohs excision of skin cancer, burn injury, or traumatic avulsion. Because facial skin carries the cosmetic and functional demands of expression, eyelid closure, and nasal/oral orifice function, surgeons favor full-thickness or split-thickness grafts, and increasingly acellular dermal substitutes, matched carefully for color, thickness, and pliability to adjacent native skin. Graft take depends on a well-vascularized recipient bed and immobilization across curved, mobile contours. Documentation should specify the exact facial subsite grafted, since ICD-10-PCS distinguishes face from scalp, ear, and neck, and should identify whether the replacement material is autologous, nonautologous, or synthetic, as this determines the correct device value for the procedure code.
Approach: External
External approach applies to procedures performed directly on the skin or mucous membrane, or on an accessible body surface, without any instrumentation passing through a puncture or orifice. It covers things like manual reduction of a fracture or excision of a skin lesion. It differs from Via Natural or Artificial Opening in that no internal passage is entered at all, only the exposed surface.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Qualifier: Cell Suspension Technique
Cell Suspension Technique specifies that a procedure used a processed suspension of the patient's own skin cells, such as an autologous cell harvesting device, rather than a traditional sheet or mesh graft. It distinguishes this newer regenerative approach, often used for burn or wound coverage, from qualifiers describing conventional full thickness or partial thickness grafting.
Coding & Documentation
Coders need the operative report to specify the material used, since the qualifier distinguishes autologous tissue from synthetic or nonautologous substitutes, and this materially changes the code selected. Documentation must also make clear that the replaced body part or region is anatomically taking the place of what was removed, not simply reinforcing existing tissue.
A frequent mistake is coding Replacement when a tissue expander, a temporary device meant to be removed later, was placed rather than a permanent implant; expander insertion is typically coded as Insertion, not Replacement. Coders also sometimes miss that a two-stage breast reconstruction requires separate codes at each encounter, one for expander insertion and later for expander removal with implant replacement. Confusion also arises between an implant placed directly after mastectomy versus one placed as a delayed procedure much later, which does not change the root operation but affects timing and history documentation coders should note.